First-line treatment of EGFR-mutated nonsmall cell lung cancer : critical review on study methodology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: European respiratory review, 23.2014. Nr. 131, S. 92-105, doi:10.1183/09059180.00008413
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2014
- Urheber
- URN
-
urn:nbn:de:hebis:30:3-355567
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sebastian, Martin
- Schmittel, Alexander
- Reck, Martin
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2014
Ähnliche Objekte (12)
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer
Hypoxia-Induced Radioresistance in Human Non-Small Cell Lung Carcinoma Cell Lines
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice
Impact of BET bromodomain inhibition on KRAS-mutated non-small cell lung cancer
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
Non-small cell lung cancer treatment
EGFR signaling in lung fibrosis
Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization
The circular RNA landscape of non-small cell lung cancer cells
Targeted cytokine-induced killer cells in non-small cell lung cancer
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer